News & Analysis on Clinical Trial Services & Contract Research And Development
Updated
Altasciences’ purchase of Vince and Associates Clinical Research highlights the industry's shift to conducting more specialized Phase I trials in patients rather than healthy volunteers, experts say.
Investment in Almac’s Northern Ireland plant will keep production costs competitive with low-cost economies, according to the company.
GSK has ‘paused’ a Phase I trial of an MS drug and fired its China R&D chief, Jingwu Zhang, after finding 'manipulated' data in a paper published in Nature Medicine in 2010.
Failure to clean up unsanitary conditions at a US plant and address cGMP violations at a facility in Puerto Rico have earned Baxter another warning from the US FDA.
Pharmas' post patent cliff push into new therapeutic areas will mean growth for the CRO industry according to Covance CEO, Joseph Herring.
Some Chinese firms wont have the 'written confirmations' required to ship APIs to the EU from July according to the German audit firm tasked with helping manufacturers prepare by Beijing industry group, CCCMHPIE.
Malicious tampering could be behind the Furosemide packaging mix-up that may have led to several deaths in France, according to Teva.
In a rare win for a CRO, Quintiles was awarded a two-year, $1.088M research grant from the Patient-Centered Outcomes Research Institute (PCORI) to compare the effectiveness of uterine fibroid treatments.